Update on the pathology of liver neoplasms

Karen Matsukuma, Matthew M. Yeh

Research output: Contribution to journalReview article

Abstract

Many advances have developed in the pathology of liver tumors in the recent decade. Examples of these advances include the use of glutamine synthetase in the diagnosis of focal nodular hyperplasia, subtyping of hepatocellular adenomas using molecular and immunohistochemical methods, the unraveling of the fusion transcript between the DNAJB1 gene and the PRKACA gene in fibrolamellar carcinoma, and the more unified classification and terminology in intrahepatic bile duct tumors and their precursor lesions. Nevertheless, challenges still remain, e.g., the differential diagnosis between well-differentiated hepatocellular carcinoma and hepatocellular adenoma; distinction among poorly differentiated hepatocellular carcinoma, cholangiocarcinoma and metastatic neoplasm; terminology of the combined hepatocellular carcinoma-cholangiocarcinoma, etc. This review aims to address updates in the pathologic diagnosis and clinical relevance of tumors of the liver and intrahepatic bile ducts in adults and their differential diagnosis and diagnostic pitfalls.

Original languageEnglish (US)
Pages (from-to)126-137
Number of pages12
JournalAnnals of Diagnostic Pathology
Volume38
DOIs
StatePublished - Feb 1 2019

Fingerprint

Liver Neoplasms
Liver Cell Adenoma
Pathology
Intrahepatic Bile Ducts
Hepatocellular Carcinoma
Cholangiocarcinoma
Terminology
Neoplasms
Differential Diagnosis
Focal Nodular Hyperplasia
Glutamate-Ammonia Ligase
Liver
Genes
Carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Update on the pathology of liver neoplasms. / Matsukuma, Karen; Yeh, Matthew M.

In: Annals of Diagnostic Pathology, Vol. 38, 01.02.2019, p. 126-137.

Research output: Contribution to journalReview article

@article{85003160d0434fadbb98f5aef63b78b4,
title = "Update on the pathology of liver neoplasms",
abstract = "Many advances have developed in the pathology of liver tumors in the recent decade. Examples of these advances include the use of glutamine synthetase in the diagnosis of focal nodular hyperplasia, subtyping of hepatocellular adenomas using molecular and immunohistochemical methods, the unraveling of the fusion transcript between the DNAJB1 gene and the PRKACA gene in fibrolamellar carcinoma, and the more unified classification and terminology in intrahepatic bile duct tumors and their precursor lesions. Nevertheless, challenges still remain, e.g., the differential diagnosis between well-differentiated hepatocellular carcinoma and hepatocellular adenoma; distinction among poorly differentiated hepatocellular carcinoma, cholangiocarcinoma and metastatic neoplasm; terminology of the combined hepatocellular carcinoma-cholangiocarcinoma, etc. This review aims to address updates in the pathologic diagnosis and clinical relevance of tumors of the liver and intrahepatic bile ducts in adults and their differential diagnosis and diagnostic pitfalls.",
author = "Karen Matsukuma and Yeh, {Matthew M.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.anndiagpath.2018.10.005",
language = "English (US)",
volume = "38",
pages = "126--137",
journal = "Annals of Diagnostic Pathology",
issn = "1092-9134",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Update on the pathology of liver neoplasms

AU - Matsukuma, Karen

AU - Yeh, Matthew M.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Many advances have developed in the pathology of liver tumors in the recent decade. Examples of these advances include the use of glutamine synthetase in the diagnosis of focal nodular hyperplasia, subtyping of hepatocellular adenomas using molecular and immunohistochemical methods, the unraveling of the fusion transcript between the DNAJB1 gene and the PRKACA gene in fibrolamellar carcinoma, and the more unified classification and terminology in intrahepatic bile duct tumors and their precursor lesions. Nevertheless, challenges still remain, e.g., the differential diagnosis between well-differentiated hepatocellular carcinoma and hepatocellular adenoma; distinction among poorly differentiated hepatocellular carcinoma, cholangiocarcinoma and metastatic neoplasm; terminology of the combined hepatocellular carcinoma-cholangiocarcinoma, etc. This review aims to address updates in the pathologic diagnosis and clinical relevance of tumors of the liver and intrahepatic bile ducts in adults and their differential diagnosis and diagnostic pitfalls.

AB - Many advances have developed in the pathology of liver tumors in the recent decade. Examples of these advances include the use of glutamine synthetase in the diagnosis of focal nodular hyperplasia, subtyping of hepatocellular adenomas using molecular and immunohistochemical methods, the unraveling of the fusion transcript between the DNAJB1 gene and the PRKACA gene in fibrolamellar carcinoma, and the more unified classification and terminology in intrahepatic bile duct tumors and their precursor lesions. Nevertheless, challenges still remain, e.g., the differential diagnosis between well-differentiated hepatocellular carcinoma and hepatocellular adenoma; distinction among poorly differentiated hepatocellular carcinoma, cholangiocarcinoma and metastatic neoplasm; terminology of the combined hepatocellular carcinoma-cholangiocarcinoma, etc. This review aims to address updates in the pathologic diagnosis and clinical relevance of tumors of the liver and intrahepatic bile ducts in adults and their differential diagnosis and diagnostic pitfalls.

UR - http://www.scopus.com/inward/record.url?scp=85059193685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059193685&partnerID=8YFLogxK

U2 - 10.1016/j.anndiagpath.2018.10.005

DO - 10.1016/j.anndiagpath.2018.10.005

M3 - Review article

C2 - 30597357

AN - SCOPUS:85059193685

VL - 38

SP - 126

EP - 137

JO - Annals of Diagnostic Pathology

JF - Annals of Diagnostic Pathology

SN - 1092-9134

ER -